Actavis

Actavis

Actavis plc was a global pharmaceutical company that, after a series of mergers, became a part of the current company Allergan plc.

Error creating thumbnail:

Actavis Logo

Overview

Originally based in Iceland, Actavis grew rapidly through both organic growth and acquisitions, eventually becoming one of the largest generic pharmaceutical companies in the world.

History

• 1956: Actavis was founded in Iceland as Pharmaco.
• 1999: The company was renamed Actavis following a merger.
• 2000s: Actavis experienced rapid growth and expansion, completing numerous acquisitions globally.
• 2015: Actavis completed the acquisition of Allergan, Inc., a transformative deal. Post-acquisition, the combined company adopted the name Allergan plc.

Notable Acquisitions

• Warner Chilcott: In 2013, Actavis acquired the specialty pharmaceutical company, enhancing its branded drug portfolio.
• Forest Laboratories: Acquired in 2014, this deal significantly expanded Actavis' branded drug business.

Key Products

Actavis had a vast product range that covered various therapeutic areas. Some of the most notable include:

• Generic formulations of blockbuster drugs.
• Specialty brand pharmaceuticals in areas such as women’s health, gastroenterology, and dermatology.

Facilities

Actavis had manufacturing, R&D, and commercial operations worldwide. Its facilities adhered to global quality standards and catered to both domestic and international markets.

Corporate Culture

Actavis was known for its dynamic culture, emphasizing innovation, growth, and a commitment to delivering high-quality pharmaceuticals to patients globally.

Controversies

The rapid growth of Actavis and its aggressive acquisition strategy did lead to certain criticisms, especially around issues of drug pricing and antitrust concerns.

See Also

• Generic drug
• Pharmaceutical industry
• Allergan
• Forest Laboratories

References

• [1] "Actavis: Company History". Actavis Corporate Archive.
• [2] "Actavis and the Landscape of Generic Pharmaceuticals". Pharmaceutical Journal.
• [3] "Actavis Completes Allergan Acquisition". Financial Times.